Affordable Access

Access to the full text

Important questions in drug allergy and hypersensitivity: consensus papers from the 2018 AAAAI/WAO international drug allergy symposium

Authors
  • Demoly, Pascal1
  • Castells, Mariana2, 3, 4
  • 1 Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Univ Montpellier and Equipe EPAR, IPLESP, INSERM Sorbonne Université, Department of Pulmonology, Division of Allergy, Paris, France , Paris (France)
  • 2 Brigham and Women’s Hospital, Harvard Medical School, Department of Medicine, Division of Rheumatology, Immunology and Allergy, 60 Fenwood Road, Room 5002N Hale BTM Building, Boston, MA, 02115, USA , Boston (United States)
  • 3 Brigham and Women’s Hospital, Harvard Medical School, Drug Hypersensitivity and Desensitizations Center, 60 Fenwood Road, Room 5002N Hale BTM Building, Boston, MA, 02115, USA , Boston (United States)
  • 4 Harvard Medical School, Mastocytosis Center, Brigham and Women’s Hospital, 60 Fenwood Road, Room 5002N Hale BTM Building, Boston, MA, 02115, USA , Boston (United States)
Type
Published Article
Journal
World Allergy Organization Journal
Publisher
BioMed Central
Publication Date
Dec 19, 2018
Volume
11
Issue
1
Identifiers
DOI: 10.1186/s40413-018-0224-1
Source
Springer Nature
Keywords
License
Green

Abstract

This article is one of a series of international consensus documents developed from the International Drug Allergy Symposium held at the Joint Congress of the American Academy of Allergy, Asthma & Immunology/World Allergy Organization on March 1, 2018, in Orlando, Florida, USA. The symposium was sponsored by The Journal of Allergy and Clinical Immunology, The Journal of Allergy and Clinical Immunology: In Practice, and The World Allergy Organization Journal and chaired by Mariana Castells, MD, PhD, and Pascal Demoly, MD, PhD.

Report this publication

Statistics

Seen <100 times